The global Chitosan Hemostatic Material market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Chitosan Hemostatic Material competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.

The North American market for Chitosan Hemostatic Material is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Chitosan Hemostatic Material is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Chitosan Hemostatic Material include Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, Hemostasis, Medcura, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Chitosan Hemostatic Material market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chitosan Hemostatic Material. The Chitosan Hemostatic Material market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Chitosan Hemostatic Material market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Chitosan Hemostatic Material manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Chitosan Hemostatic Material Market Report

Report Metric	Details
Report Name	Chitosan Hemostatic Material Market
Segment by Type	Hemostatic Gauze Hemostatic Powder Hemostatic Sponge Others
by Application	Surgery First Aid
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, Hemostasis, Medcura, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed, Haiyuan Hairun, Yancheng Yankang Medical Equipment, Success Bio-Tech, Lanhine Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Chitosan Hemostatic Material manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Chitosan Hemostatic Material sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Chitosan Hemostatic Material Market report?

Ans: The main players in the Chitosan Hemostatic Material Market are Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, Hemostasis, Medcura, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, Biotemed, Haiyuan Hairun, Yancheng Yankang Medical Equipment, Success Bio-Tech, Lanhine Medical

What are the Application segmentation covered in the Chitosan Hemostatic Material Market report?

Ans: The Applications covered in the Chitosan Hemostatic Material Market report are Surgery, First Aid

What are the Type segmentation covered in the Chitosan Hemostatic Material Market report?

Ans: The Types covered in the Chitosan Hemostatic Material Market report are Hemostatic Gauze, Hemostatic Powder, Hemostatic Sponge, Others

1 Chitosan Hemostatic Material Market Overview

1.1 Product Definition

1.2 Chitosan Hemostatic Material by Type

1.2.1 Global Chitosan Hemostatic Material Market Value by Type: 2025 vs 2032

1.2.2 Hemostatic Gauze

1.2.3 Hemostatic Powder

1.2.4 Hemostatic Sponge

1.2.5 Others

1.3 Chitosan Hemostatic Material by Application

1.3.1 Global Chitosan Hemostatic Material Market Value by Application: 2025 vs 2032

1.3.2 Surgery

1.3.3 First Aid

1.4 Global Chitosan Hemostatic Material Market Size Estimates and Forecasts

1.4.1 Global Chitosan Hemostatic Material Revenue 2021–2032

1.4.2 Global Chitosan Hemostatic Material Sales 2021–2032

1.4.3 Global Chitosan Hemostatic Material Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Chitosan Hemostatic Material Market Competition by Manufacturers

2.1 Global Chitosan Hemostatic Material Sales Market Share by Manufacturers (2021–2026)

2.2 Global Chitosan Hemostatic Material Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Chitosan Hemostatic Material Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Chitosan Hemostatic Material, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Chitosan Hemostatic Material, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Chitosan Hemostatic Material, Product Types and Applications

2.7 Global Key Manufacturers of Chitosan Hemostatic Material, Date of Entry into the Industry

2.8 Global Chitosan Hemostatic Material Market Competitive Situation and Trends

2.8.1 Global Chitosan Hemostatic Material Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Chitosan Hemostatic Material Players Market Share by Revenue

2.8.3 Global Chitosan Hemostatic Material Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Chitosan Hemostatic Material Market Scenario by Region

3.1 Global Chitosan Hemostatic Material Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Chitosan Hemostatic Material Sales by Region: 2021–2032

3.2.1 Global Chitosan Hemostatic Material Sales by Region: 2021–2026

3.2.2 Global Chitosan Hemostatic Material Sales by Region: 2027–2032

3.3 Global Chitosan Hemostatic Material Revenue by Region: 2021–2032

3.3.1 Global Chitosan Hemostatic Material Revenue by Region: 2021–2026

3.3.2 Global Chitosan Hemostatic Material Revenue by Region: 2027–2032

3.4 North America Chitosan Hemostatic Material Market Facts & Figures by Country

3.4.1 North America Chitosan Hemostatic Material Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Chitosan Hemostatic Material Sales by Country (2021–2032)

3.4.3 North America Chitosan Hemostatic Material Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Chitosan Hemostatic Material Market Facts & Figures by Country

3.5.1 Europe Chitosan Hemostatic Material Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Chitosan Hemostatic Material Sales by Country (2021–2032)

3.5.3 Europe Chitosan Hemostatic Material Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chitosan Hemostatic Material Market Facts & Figures by Region

3.6.1 Asia Pacific Chitosan Hemostatic Material Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Chitosan Hemostatic Material Sales by Region (2021–2032)

3.6.3 Asia Pacific Chitosan Hemostatic Material Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Chitosan Hemostatic Material Market Facts & Figures by Country

3.7.1 Latin America Chitosan Hemostatic Material Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Chitosan Hemostatic Material Sales by Country (2021–2032)

3.7.3 Latin America Chitosan Hemostatic Material Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Chitosan Hemostatic Material Market Facts & Figures by Country

3.8.1 Middle East and Africa Chitosan Hemostatic Material Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Chitosan Hemostatic Material Sales by Country (2021–2032)

3.8.3 Middle East and Africa Chitosan Hemostatic Material Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Chitosan Hemostatic Material Sales by Type (2021–2032)

4.1.1 Global Chitosan Hemostatic Material Sales by Type (2021–2026)

4.1.2 Global Chitosan Hemostatic Material Sales by Type (2027–2032)

4.1.3 Global Chitosan Hemostatic Material Sales Market Share by Type (2021–2032)

4.2 Global Chitosan Hemostatic Material Revenue by Type (2021–2032)

4.2.1 Global Chitosan Hemostatic Material Revenue by Type (2021–2026)

4.2.2 Global Chitosan Hemostatic Material Revenue by Type (2027–2032)

4.2.3 Global Chitosan Hemostatic Material Revenue Market Share by Type (2021–2032)

4.3 Global Chitosan Hemostatic Material Price by Type (2021–2032)

5 Segment by Application

5.1 Global Chitosan Hemostatic Material Sales by Application (2021–2032)

5.1.1 Global Chitosan Hemostatic Material Sales by Application (2021–2026)

5.1.2 Global Chitosan Hemostatic Material Sales by Application (2027–2032)

5.1.3 Global Chitosan Hemostatic Material Sales Market Share by Application (2021–2032)

5.2 Global Chitosan Hemostatic Material Revenue by Application (2021–2032)

5.2.1 Global Chitosan Hemostatic Material Revenue by Application (2021–2026)

5.2.2 Global Chitosan Hemostatic Material Revenue by Application (2027–2032)

5.2.3 Global Chitosan Hemostatic Material Revenue Market Share by Application (2021–2032)

5.3 Global Chitosan Hemostatic Material Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Anscare

6.1.1 Anscare Company Information

6.1.2 Anscare Description and Business Overview

6.1.3 Anscare Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Anscare Chitosan Hemostatic Material Product Portfolio

6.1.5 Anscare Recent Developments/Updates

6.2 Tricol Biomedical

6.2.1 Tricol Biomedical Company Information

6.2.2 Tricol Biomedical Description and Business Overview

6.2.3 Tricol Biomedical Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Tricol Biomedical Chitosan Hemostatic Material Product Portfolio

6.2.5 Tricol Biomedical Recent Developments/Updates

6.3 Advamedica

6.3.1 Advamedica Company Information

6.3.2 Advamedica Description and Business Overview

6.3.3 Advamedica Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Advamedica Chitosan Hemostatic Material Product Portfolio

6.3.5 Advamedica Recent Developments/Updates

6.4 Hemoflex

6.4.1 Hemoflex Company Information

6.4.2 Hemoflex Description and Business Overview

6.4.3 Hemoflex Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Hemoflex Chitosan Hemostatic Material Product Portfolio

6.4.5 Hemoflex Recent Developments/Updates

6.5 Mermaid Medical

6.5.1 Mermaid Medical Company Information

6.5.2 Mermaid Medical Description and Business Overview

6.5.3 Mermaid Medical Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Mermaid Medical Chitosan Hemostatic Material Product Portfolio

6.5.5 Mermaid Medical Recent Developments/Updates

6.6 Hemostasis

6.6.1 Hemostasis Company Information

6.6.2 Hemostasis Description and Business Overview

6.6.3 Hemostasis Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Hemostasis Chitosan Hemostatic Material Product Portfolio

6.6.5 Hemostasis Recent Developments/Updates

6.7 Medcura

6.7.1 Medcura Company Information

6.7.2 Medcura Description and Business Overview

6.7.3 Medcura Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Medcura Chitosan Hemostatic Material Product Portfolio

6.7.5 Medcura Recent Developments/Updates

6.8 BioPharm Med

6.8.1 BioPharm Med Company Information

6.8.2 BioPharm Med Description and Business Overview

6.8.3 BioPharm Med Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 BioPharm Med Chitosan Hemostatic Material Product Portfolio

6.8.5 BioPharm Med Recent Developments/Updates

6.9 MedTrade Products

6.9.1 MedTrade Products Company Information

6.9.2 MedTrade Products Description and Business Overview

6.9.3 MedTrade Products Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 MedTrade Products Chitosan Hemostatic Material Product Portfolio

6.9.5 MedTrade Products Recent Developments/Updates

6.10 Shijiazhuang Yishengtang Medical Product

6.10.1 Shijiazhuang Yishengtang Medical Product Company Information

6.10.2 Shijiazhuang Yishengtang Medical Product Description and Business Overview

6.10.3 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product Portfolio

6.10.5 Shijiazhuang Yishengtang Medical Product Recent Developments/Updates

6.11 Biotemed

6.11.1 Biotemed Company Information

6.11.2 Biotemed Description and Business Overview

6.11.3 Biotemed Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Biotemed Chitosan Hemostatic Material Product Portfolio

6.11.5 Biotemed Recent Developments/Updates

6.12 Haiyuan Hairun

6.12.1 Haiyuan Hairun Company Information

6.12.2 Haiyuan Hairun Description and Business Overview

6.12.3 Haiyuan Hairun Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Haiyuan Hairun Chitosan Hemostatic Material Product Portfolio

6.12.5 Haiyuan Hairun Recent Developments/Updates

6.13 Yancheng Yankang Medical Equipment

6.13.1 Yancheng Yankang Medical Equipment Company Information

6.13.2 Yancheng Yankang Medical Equipment Description and Business Overview

6.13.3 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product Portfolio

6.13.5 Yancheng Yankang Medical Equipment Recent Developments/Updates

6.14 Success Bio-Tech

6.14.1 Success Bio-Tech Company Information

6.14.2 Success Bio-Tech Description and Business Overview

6.14.3 Success Bio-Tech Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Success Bio-Tech Chitosan Hemostatic Material Product Portfolio

6.14.5 Success Bio-Tech Recent Developments/Updates

6.15 Lanhine Medical

6.15.1 Lanhine Medical Company Information

6.15.2 Lanhine Medical Description and Business Overview

6.15.3 Lanhine Medical Chitosan Hemostatic Material Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Lanhine Medical Chitosan Hemostatic Material Product Portfolio

6.15.5 Lanhine Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chitosan Hemostatic Material Industry Chain Analysis

7.2 Chitosan Hemostatic Material Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chitosan Hemostatic Material Production Mode & Process Analysis

7.4 Chitosan Hemostatic Material Sales and Marketing

7.4.1 Chitosan Hemostatic Material Sales Channels

7.4.2 Chitosan Hemostatic Material Distributors

7.5 Chitosan Hemostatic Material Customer Analysis

8 Chitosan Hemostatic Material Market Dynamics

8.1 Chitosan Hemostatic Material Industry Trends

8.2 Chitosan Hemostatic Material Market Drivers

8.3 Chitosan Hemostatic Material Market Challenges

8.4 Chitosan Hemostatic Material Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shijiazhuang Yishengtang Medical Product

Biotemed

Haiyuan Hairun

Yancheng Yankang Medical Equipment

Success Bio-Tech

Lanhine Medical

List of Tables

Table 1. Global Chitosan Hemostatic Material Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Chitosan Hemostatic Material Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Chitosan Hemostatic Material Market Competitive Situation by Manufacturers in 2025

Table 4. Global Chitosan Hemostatic Material Sales (Units) of Key Manufacturers (2021–2026)

Table 5. Global Chitosan Hemostatic Material Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Chitosan Hemostatic Material Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Chitosan Hemostatic Material Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Chitosan Hemostatic Material Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Chitosan Hemostatic Material, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Chitosan Hemostatic Material, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Chitosan Hemostatic Material, Product Types and Applications

Table 12. Global Key Manufacturers of Chitosan Hemostatic Material, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chitosan Hemostatic Material Companies by Tier (Tier 1, Tier 2, Tier 3), based on Chitosan Hemostatic Material Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chitosan Hemostatic Material Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Chitosan Hemostatic Material Sales by Region (Units), 2021–2026

Table 18. Global Chitosan Hemostatic Material Sales Market Share by Region (2021–2026)

Table 19. Global Chitosan Hemostatic Material Sales by Region (Units), 2027–2032

Table 20. Global Chitosan Hemostatic Material Sales Market Share by Region (2027–2032)

Table 21. Global Chitosan Hemostatic Material Revenue by Region (US$ Million), 2021–2026

Table 22. Global Chitosan Hemostatic Material Revenue Market Share by Region (2021–2026)

Table 23. Global Chitosan Hemostatic Material Revenue by Region (US$ Million), 2027–2032

Table 24. Global Chitosan Hemostatic Material Revenue Market Share by Region (2027–2032)

Table 25. North America Chitosan Hemostatic Material Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Chitosan Hemostatic Material Sales by Country (Units), 2021–2026

Table 27. North America Chitosan Hemostatic Material Sales by Country (Units), 2027–2032

Table 28. North America Chitosan Hemostatic Material Revenue by Country (US$ Million), 2021–2026

Table 29. North America Chitosan Hemostatic Material Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Chitosan Hemostatic Material Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Chitosan Hemostatic Material Sales by Country (Units), 2021–2026

Table 32. Europe Chitosan Hemostatic Material Sales by Country (Units), 2027–2032

Table 33. Europe Chitosan Hemostatic Material Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Chitosan Hemostatic Material Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Chitosan Hemostatic Material Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Chitosan Hemostatic Material Sales by Region (Units), 2021–2026

Table 37. Asia Pacific Chitosan Hemostatic Material Sales by Region (Units), 2027–2032

Table 38. Asia Pacific Chitosan Hemostatic Material Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Chitosan Hemostatic Material Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Chitosan Hemostatic Material Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Chitosan Hemostatic Material Sales by Country (Units), 2021–2026

Table 42. Latin America Chitosan Hemostatic Material Sales by Country (Units), 2027–2032

Table 43. Latin America Chitosan Hemostatic Material Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Chitosan Hemostatic Material Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Chitosan Hemostatic Material Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Chitosan Hemostatic Material Sales by Country (Units), 2021–2026

Table 47. Middle East and Africa Chitosan Hemostatic Material Sales by Country (Units), 2027–2032

Table 48. Middle East and Africa Chitosan Hemostatic Material Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Chitosan Hemostatic Material Revenue by Country (US$ Million), 2027–2032

Table 50. Global Chitosan Hemostatic Material Sales (Units) by Type (2021–2026)

Table 51. Global Chitosan Hemostatic Material Sales (Units) by Type (2027–2032)

Table 52. Global Chitosan Hemostatic Material Sales Market Share by Type (2021–2026)

Table 53. Global Chitosan Hemostatic Material Sales Market Share by Type (2027–2032)

Table 54. Global Chitosan Hemostatic Material Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Chitosan Hemostatic Material Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Chitosan Hemostatic Material Revenue Market Share by Type (2021–2026)

Table 57. Global Chitosan Hemostatic Material Revenue Market Share by Type (2027–2032)

Table 58. Global Chitosan Hemostatic Material Price (US$/Unit) by Type (2021–2026)

Table 59. Global Chitosan Hemostatic Material Price (US$/Unit) by Type (2027–2032)

Table 60. Global Chitosan Hemostatic Material Sales (Units) by Application (2021–2026)

Table 61. Global Chitosan Hemostatic Material Sales (Units) by Application (2027–2032)

Table 62. Global Chitosan Hemostatic Material Sales Market Share by Application (2021–2026)

Table 63. Global Chitosan Hemostatic Material Sales Market Share by Application (2027–2032)

Table 64. Global Chitosan Hemostatic Material Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Chitosan Hemostatic Material Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Chitosan Hemostatic Material Revenue Market Share by Application (2021–2026)

Table 67. Global Chitosan Hemostatic Material Revenue Market Share by Application (2027–2032)

Table 68. Global Chitosan Hemostatic Material Price (US$/Unit) by Application (2021–2026)

Table 69. Global Chitosan Hemostatic Material Price (US$/Unit) by Application (2027–2032)

Table 70. Anscare Company Information

Table 71. Anscare Description and Business Overview

Table 72. Anscare Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Anscare Chitosan Hemostatic Material Product

Table 74. Anscare Recent Developments/Updates

Table 75. Tricol Biomedical Company Information

Table 76. Tricol Biomedical Description and Business Overview

Table 77. Tricol Biomedical Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Tricol Biomedical Chitosan Hemostatic Material Product

Table 79. Tricol Biomedical Recent Developments/Updates

Table 80. Advamedica Company Information

Table 81. Advamedica Description and Business Overview

Table 82. Advamedica Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Advamedica Chitosan Hemostatic Material Product

Table 84. Advamedica Recent Developments/Updates

Table 85. Hemoflex Company Information

Table 86. Hemoflex Description and Business Overview

Table 87. Hemoflex Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Hemoflex Chitosan Hemostatic Material Product

Table 89. Hemoflex Recent Developments/Updates

Table 90. Mermaid Medical Company Information

Table 91. Mermaid Medical Description and Business Overview

Table 92. Mermaid Medical Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Mermaid Medical Chitosan Hemostatic Material Product

Table 94. Mermaid Medical Recent Developments/Updates

Table 95. Hemostasis Company Information

Table 96. Hemostasis Description and Business Overview

Table 97. Hemostasis Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Hemostasis Chitosan Hemostatic Material Product

Table 99. Hemostasis Recent Developments/Updates

Table 100. Medcura Company Information

Table 101. Medcura Description and Business Overview

Table 102. Medcura Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. Medcura Chitosan Hemostatic Material Product

Table 104. Medcura Recent Developments/Updates

Table 105. BioPharm Med Company Information

Table 106. BioPharm Med Description and Business Overview

Table 107. BioPharm Med Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. BioPharm Med Chitosan Hemostatic Material Product

Table 109. BioPharm Med Recent Developments/Updates

Table 110. MedTrade Products Company Information

Table 111. MedTrade Products Description and Business Overview

Table 112. MedTrade Products Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. MedTrade Products Chitosan Hemostatic Material Product

Table 114. MedTrade Products Recent Developments/Updates

Table 115. Shijiazhuang Yishengtang Medical Product Company Information

Table 116. Shijiazhuang Yishengtang Medical Product Description and Business Overview

Table 117. Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product

Table 119. Shijiazhuang Yishengtang Medical Product Recent Developments/Updates

Table 120. Biotemed Company Information

Table 121. Biotemed Description and Business Overview

Table 122. Biotemed Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 123. Biotemed Chitosan Hemostatic Material Product

Table 124. Biotemed Recent Developments/Updates

Table 125. Haiyuan Hairun Company Information

Table 126. Haiyuan Hairun Description and Business Overview

Table 127. Haiyuan Hairun Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 128. Haiyuan Hairun Chitosan Hemostatic Material Product

Table 129. Haiyuan Hairun Recent Developments/Updates

Table 130. Yancheng Yankang Medical Equipment Company Information

Table 131. Yancheng Yankang Medical Equipment Description and Business Overview

Table 132. Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 133. Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product

Table 134. Yancheng Yankang Medical Equipment Recent Developments/Updates

Table 135. Success Bio-Tech Company Information

Table 136. Success Bio-Tech Description and Business Overview

Table 137. Success Bio-Tech Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 138. Success Bio-Tech Chitosan Hemostatic Material Product

Table 139. Success Bio-Tech Recent Developments/Updates

Table 140. Lanhine Medical Company Information

Table 141. Lanhine Medical Description and Business Overview

Table 142. Lanhine Medical Chitosan Hemostatic Material Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 143. Lanhine Medical Chitosan Hemostatic Material Product

Table 144. Lanhine Medical Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Chitosan Hemostatic Material Distributors List

Table 148. Chitosan Hemostatic Material Customers List

Table 149. Chitosan Hemostatic Material Market Trends

Table 150. Chitosan Hemostatic Material Market Drivers

Table 151. Chitosan Hemostatic Material Market Challenges

Table 152. Chitosan Hemostatic Material Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Chitosan Hemostatic Material

Figure 2. Global Chitosan Hemostatic Material Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Chitosan Hemostatic Material Market Share by Type: 2025 & 2032

Figure 4. Hemostatic Gauze Product Picture

Figure 5. Hemostatic Powder Product Picture

Figure 6. Hemostatic Sponge Product Picture

Figure 7. Others Product Picture

Figure 8. Global Chitosan Hemostatic Material Market Value by Application (US$ Million), 2021–2032

Figure 9. Global Chitosan Hemostatic Material Market Share by Application: 2025 & 2032

Figure 10. Surgery

Figure 11. First Aid

Figure 12. Global Chitosan Hemostatic Material Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Chitosan Hemostatic Material Market Size (US$ Million), 2021–2032

Figure 14. Global Chitosan Hemostatic Material Sales (Units), 2021–2032

Figure 15. Global Chitosan Hemostatic Material Average Price (US$/Unit), 2021–2032

Figure 16. Chitosan Hemostatic Material Report Years Considered

Figure 17. Chitosan Hemostatic Material Sales Share by Manufacturers in 2025

Figure 18. Global Chitosan Hemostatic Material Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global Chitosan Hemostatic Material Players: Market Share by Revenue in Chitosan Hemostatic Material in 2025

Figure 20. Chitosan Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global Chitosan Hemostatic Material Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America Chitosan Hemostatic Material Sales Market Share by Country (2021–2032)

Figure 23. North America Chitosan Hemostatic Material Revenue Market Share by Country (2021–2032)

Figure 24. United States Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe Chitosan Hemostatic Material Sales Market Share by Country (2021–2032)

Figure 27. Europe Chitosan Hemostatic Material Revenue Market Share by Country (2021–2032)

Figure 28. Germany Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific Chitosan Hemostatic Material Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific Chitosan Hemostatic Material Revenue Market Share by Region (2021–2032)

Figure 35. China Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Southeast Asia Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Chitosan Hemostatic Material Sales Market Share by Country (2021–2032)

Figure 43. Latin America Chitosan Hemostatic Material Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Colombia Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Middle East and Africa Chitosan Hemostatic Material Sales Market Share by Country (2021–2032)

Figure 49. Middle East and Africa Chitosan Hemostatic Material Revenue Market Share by Country (2021–2032)

Figure 50. Turkey Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Saudi Arabia Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. UAE Chitosan Hemostatic Material Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Global Sales Market Share of Chitosan Hemostatic Material by Type (2021–2032)

Figure 54. Global Revenue Market Share of Chitosan Hemostatic Material by Type (2021–2032)

Figure 55. Global Chitosan Hemostatic Material Price (US$/Unit) by Type (2021–2032)

Figure 56. Global Sales Market Share of Chitosan Hemostatic Material by Application (2021–2032)

Figure 57. Global Revenue Market Share of Chitosan Hemostatic Material by Application (2021–2032)

Figure 58. Global Chitosan Hemostatic Material Price (US$/Unit) by Application (2021–2032)

Figure 59. Chitosan Hemostatic Material Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions